Results 21 to 30 of about 2,874,529 (208)

Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management

Frontiers in Endocrinology, 2020
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance.
Alison M. Boyce, Alisa E. Lee, Kelly L. Roszko, Rachel I. Gafni   +3 more
doaj   +2 more sources

The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23

JCRPE, 2022
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder. Topical sodium thiosulfate (STS) and acetazolamide can be a safe and effective treatment for patients who do not respond to conventional therapy for ectopic ...
Hakan Döneray, Ayşe Özden, Kadri Gürbüz   +2 more
doaj   +2 more sources

Tumoral Calcinosis [PDF]

Medical Journal Armed Forces India, 2007
A, Alam, M N, Sree Ram, K, Manrai, R, Bhardwaj   +3 more
openaire   +3 more sources

Tumoral calcinosis of unusual location in a chronic hemodialysis patient. [PDF]

BJR Case Rep, 2023
Tumoral calcinosis is a rare cause of intratissular calcifications in hemodialysis patients with chronic renal failure. Its frequency is estimated between 0.5 and 7% of patients. We illustrate through a case of unusual localization diagnosed in Ibn Rochd
Sakhy Y, Taoussi R, Ndayishimiye V, Sabiri M, Labied M, Lembarki G, El Manjra S, Lezar S, Essodegui F.   +8 more
europepmc   +2 more sources

A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a GALNT3 variant. [PDF]

Clin Pediatr Endocrinol, 2023
. Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare, inherited autosomal recessive disorder caused by fibroblast growth factor-23 (FGF23), N-acetylgalactosaminyltransferase 3 (GALNT3), or Klotho (KL) gene variants.
Nishimura-Kinoshita N, Ohata Y, Sawai H, Izawa M, Takeyari S, Kubota T, Omae Y, Ozono K, Tokunaga K, Hamajima T.   +9 more
europepmc   +2 more sources

Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports. [PDF]

BMC Nephrol, 2023
Background Uremic tumoral calcinosis (UTC) is a rare complication in hemodialysis patients, whose mechanism remains incompletely understood.
Li J, Li X, Dong X, Ma L, Guo Z, Chen X.
europepmc   +2 more sources

A GALNT3 mutation causing Hyperphosphatemic familial Tumoral calcinosis. [PDF]

Mol Genet Metab Rep
Wu A, Yang B, Yu X.
europepmc   +2 more sources

Tumoral calcinosis in chronic renal failure: A case report and literature review. [PDF]

Int J Surg Case Rep
Andriandi, Husnul F, Tirta C.
europepmc   +2 more sources

Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis. [PDF]

J Bone Miner Res
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) is a rare disorder caused by deficient FGF23 signaling and resultant ectopic calcification. In this study, we systematically characterized and quantified macro- and micro-calcification in an HFTC ...
Sheppard AJ, Paravastu SS, Farhadi F, Donnelly E, Hartley IR, Gafni RI, Saboury B, Collins MT, Roszko KL.   +8 more
europepmc   +2 more sources

PRIMARY NORMO-PHOSPHATEMIC TUMORAL CALCINOSIS - A RARE ENTITY [PDF]

International Journal of Advanced Research, 2022
Tumoral calcinosis is a rare benign condition, characterized by massive deposition of calcium salts into peri-articular soft tissues. Majority are secondary to underlying chronic disorders like chronic renal failure.
Shashi Ranjan, Santosh Reang, Anupam Debnath, Chidanand Golasangi   +3 more
openalex   +2 more sources